https://www.prnewswire.com/news-releases/fusion-pharmaceuticals-appoints-dmitri-bobilev-md-as-chief-medical-officer-301670776.html
Fusion Pharmaceuticals Appoints Dmitri Bobilev, M.D. as Chief Medical Officer
/PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as...
m dfusionpharmaceuticalsappointsdmitri